Observe Medical Asa Total Assets
Observe Medical Asa total assets. Based on the latest financial reports, Observe Medical Asa (OBSRV) holds total assets worth Nkr101.17 Million NOK (≈ $10.65 Million USD) as of December 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see OBSRV market cap for the company's overall valuation and market capitalisation.
Total Assets of Observe Medical Asa (2016–2025)
Total assets of Observe Medical Asa from 2016 to 2025. This chart illustrates how Observe Medical Asa's total assets have evolved over time, based on quarterly financial data. See OBSRV live share price for real-time trading data and today's change.
Observe Medical Asa - Asset Composition Analysis
Observe Medical Asa Total Assets Breakdown (December 2025)
Observe Medical Asa total assets breakdown as of December 2025. Observe Medical Asa's total assets of Nkr101.17 Million consist of 21.1% current assets and 78.9% non-current assets.
| Asset Category | Amount (NOK) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Nkr11.50 Million | 11.4% |
| Accounts Receivable | Nkr0.00 | 0.0% |
| Inventory | Nkr7.48 Million | 7.4% |
| Property, Plant & Equipment | Nkr59.00K | 0.1% |
| Intangible Assets | Nkr44.60 Million | 44.1% |
| Goodwill | Nkr35.16 Million | 34.8% |
Asset Composition Trend (2016–2025)
This chart illustrates how Observe Medical Asa's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Observe Medical Asa (OBSRV) working capital ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Observe Medical Asa's current assets represent 21.1% of total assets in 2025, an increase from 16.1% in 2016.
- Cash Position: Cash and equivalents constituted 11.4% of total assets in 2025, up from 5.1% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 78.0% of total assets, a decrease from 82.0% in 2016.
- Asset Diversification: The largest asset category is intangible assets at 44.1% of total assets.
Observe Medical Asa Competitors by Total Assets
Key competitors of Observe Medical Asa based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
HOB Biotech Group Corp Ltd
SHG:688656
|
China | CN¥916.43 Million |
|
L&C Bio Co. Ltd
KQ:290650
|
Korea | ₩497.94 Billion |
|
Applied BioCode
TW:6598
|
Taiwan | NT$1.03 Billion |
|
Oncosil Medical Ltd
AU:OSL
|
Australia | AU$7.13 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Cleo Diagnostics Ltd
AU:COV
|
Australia | AU$9.96 Million |
|
Radiant Innovation
TWO:3373
|
Taiwan | NT$859.52 Million |
|
MedX Health Corp
V:MDX
|
Canada | CA$1.26 Million |
Observe Medical Asa - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.48 | 0.20 | 3.00 |
| Quick Ratio | 0.31 | 0.11 | 2.23 |
| Cash Ratio | 0.26 | 0.03 | 0.00 |
| Working Capital | Nkr-23.04 Million | Nkr-48.18 Million | Nkr19.86 Million |
Observe Medical Asa - Advanced Valuation Insights
This section examines the relationship between Observe Medical Asa's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 4.44 |
| Latest Market Cap to Assets Ratio | 0.12 |
| Asset Growth Rate (YoY) | -31.8% |
| Total Assets | Nkr101.17 Million |
| Market Capitalization | $12.26 Million USD |
Valuation Analysis
Below Book Valuation: The market values Observe Medical Asa's assets below their book value (0.12x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Observe Medical Asa's assets decreased by 31.8% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Observe Medical Asa (2016–2025)
The table below shows the annual total assets of Observe Medical Asa from 2016 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | Nkr101.17 Million ≈ $10.65 Million |
-31.83% |
| 2024-12-31 | Nkr148.41 Million ≈ $15.62 Million |
-39.38% |
| 2023-12-31 | Nkr244.82 Million ≈ $25.76 Million |
+13.44% |
| 2022-12-31 | Nkr215.81 Million ≈ $22.71 Million |
+200.83% |
| 2021-12-31 | Nkr71.74 Million ≈ $7.55 Million |
-18.23% |
| 2020-12-31 | Nkr87.73 Million ≈ $9.23 Million |
+58.55% |
| 2019-12-31 | Nkr55.33 Million ≈ $5.82 Million |
-5.95% |
| 2018-12-31 | Nkr58.83 Million ≈ $6.19 Million |
-8.13% |
| 2017-12-31 | Nkr64.04 Million ≈ $6.74 Million |
-7.25% |
| 2016-12-31 | Nkr69.04 Million ≈ $7.26 Million |
-- |
About Observe Medical Asa
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a dig… Read more